“CardioMap is a unique technology that can meet an unmet need in a large and growing market. We feel very confident that we can capitalize on the CardioMap opportunity to increase patient care and create significant shareholder value. In addition to CardioMap, Odyssey has several acquisition targets it is pursuing.”
- Loading stock data...
Odyssey Group International, Inc.’s shares are currently traded on the OTBB (ODYY↑) and the Company has a significant asset in the CardioMap heart monitoring and screening device. Click on the following link to review the Company’s SEC filings:
For more information on Odyssey Group International, please complete the following contact form and a member of our investor relations team will respond shortly: